Tag: Astellas Pharma Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Astellas Pharma Inc.

Zevin Asset Management Llc Buys AllianceBernstein Holding LP, ONEOK Inc, General Mills Inc ...

Added to Collection on: 2019-04-29 01:37:30

Tags for this article:

General Mills Inc.
Sysco Corp.
W.P. Carey Inc.
Telstra Corp Ltd
Starbucks Corp
Telenor ASA
ONEOK Inc.
Iron Mountain Inc
Swiss Re AG
AllianceBernstein Holding LP
Seven & i Holdings Co Ltd
Svenska Handelsbanken
BYD Co Ltd.
Astellas Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
Robotics Market Growth 2020 Industry Share, Trend, Segment by Top Key Players Analysis ...

Added to Collection on: 2020-01-16 15:18:45

Tags for this article:

Companies
Health
Antineoplastic drugs
Lung cancer
Cancer treatments
Oncology
Boehringer Ingelheim
Hoffmann-La Roche
Cancer
Novartis
Targeted therapy
Small-cell carcinoma
Celgene Corporation
Merck & Co. Inc
Amgen Inc.
Eli Lilly and Company
Takeda Pharmaceutical Company Limited
Allergan
Bristol-Myers Squibb Company
, Johnson &Johnson
Ono Pharmaceutical Co. Ltd.
Astellas Pharma Inc.
Sun Pharmaceutical Industries Ltd.
Pfizer Inc.
Novartis AG
Boehringer Ingelheim International GmbH
F. Hoffmann-La Roche Ltd.
DR . REDDY
Sanofi
Teva Pharmaceutical Industries Ltd
Sumitomo Dainippon Pharma Co. Ltd.
AstraZeneca
GlaxoSmithKline plc

Click the tags to see associated articles and topics

View Article Details
Astellas' XOSPATA® (gilteritinib) Receives Conditional Approval by China's National Medical ...

Added to Collection on: 2021-02-04 03:00:00

Tags for this article:

Chemical compounds
Tyrosine kinase receptors
Cancer
Clinical medicine
CD135
Piperidines
Tyrosine kinase inhibitors
Orphan drugs
Gilteritinib
Acute myeloid leukemia
Leukemia
Chemotherapy
Astellas Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
Astellas Pharma : Notice Regarding Impairment Loss Following the Termination of DNA Vaccine ...

Added to Collection on: 2021-06-17 06:56:15

Tags for this article:

Life Sciences
Astellas Pharma
Mitsubishi UFJ Financial Group
Health sciences
Companies
Pharmaceutical industry
Astellas Pharma Inc.
Immunomic Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
FDA Approves PADCEV, KEYTRUDA Combo as First ADC, PD-1 Bladder Cancer Treatment

Added to Collection on: 2023-12-16 11:47:02

Tags for this article:

Antineoplastic drugs
Breakthrough therapy
Orphan drugs
Cancer immunotherapy
Pembrolizumab
Cancer treatments
Transitional cell carcinoma
Bladder cancer
Enfortumab vedotin
Chemotherapy
Head and neck cancer
Antibody-drug conjugate
Astellas Pharma Inc.
Pfizer Inc.
Cisplatin
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Astellas Provides Update on Zolbetuximab Biologics License Application in U.S. | Antibodies

Added to Collection on: 2024-01-09 15:19:16

Tags for this article:

Food and Drug Administration
Astellas Pharma
Mitsubishi UFJ Financial Group
Monoclonal antibodies
Zolbetuximab
CLDN18
Prescription Drug User Fee Act
Biologics license application
u.s. food and drug administration
Astellas Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
Astellas Pharma's VYLOY Receives FDA Approval For Treatment Of Advanced Gastric And ...

Added to Collection on: 2024-10-18 21:10:47

Tags for this article:

Orphan drugs
Antineoplastic drugs
Monoclonal antibodies
Astellas Pharma
Mitsubishi UFJ Financial Group
Zolbetuximab
Antibody-drug conjugates
HER2
Immunohistochemistry
Companion diagnostic
Disitamab vedotin
Trastuzumab deruxtecan
Astellas Pharma Inc.
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Astellas' VYLOY™ (zolbetuximab-clzb) Approved by U.S. FDA for Treatment of Advanced ...

Added to Collection on: 2024-10-18 20:48:07

Tags for this article:

Orphan drugs
Antineoplastic drugs
Antibody-drug conjugates
Cancer treatments
Stomach cancer
Astellas Pharma
HER2
Pancreatic cancer
Chemotherapy regimen
Pembrolizumab
Trastuzumab deruxtecan
Astellas Pharma Inc.
Astellas Inc.
United States
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Book a Demo